Compare Duke Energy Corp (DUK) vs Twist Bioscience Corp (TWST) Price & Performance

Duke Energy CorpTrade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Duke Energy Corp vs Twist Bioscience Corp — how do they compare? Duke Energy Corp trades at $122.8 (market cap $96.05B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Duke Energy Corp is far larger — about 12.4× Twist Bioscience Corp's market cap, and Duke Energy Corp pays a 3.52% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

	DUK	TWST
Market Cap	$96.05B	$7.72B
Sector	Utilities	Health
52-Week High	$133.46	$124.88
52-Week Low	$113.99	$24.16
Enterprise Value	$188.56B	$7.65B
Dividend Yield	3.52%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DUK

Severe storms cut power to 160,000 Duke Energy customers in Greater Cincinnati, restoration ongoing.PRNewsWire · 12 hours agoBearish Call 811 before digging to prevent nearly 4,500 utility line damages reported in 2026 so far.PRNewsWire · 23 hours agoNeutral Duke Energy prices $1.75B equity units offering to fund debt redemption and corporate needsPRNewsWire · 1 day agoNeutral View details →

TWST

View details →

About Duke Energy Corp

Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.